98%
921
2 minutes
20
Background: Continuous positive airway pressure (CPAP) adherence may vary based on the study design and country.
Objectives: To investigate long-term CPAP adherence and elucidate associated factors.
Methods: A multicenter retrospective observational cohort study was conducted over two years. The study included patients diagnosed with obstructive sleep apnea who were prescribed CPAP (n = 1261). Adherence was assessed for 90 days and 365 days. Centers for Medicare and Medicaid Services (CMS) criteria (≥4 h/night on ≥70 % of nights) and research adherence criteria (≥4 h/night during the observational period) were used. Factors influencing CPAP adherence (CMS criteria) during 90 and 365 days were also evaluated. Continuous variables were categorized into low, middle, and high classes, and logistic regression analysis with interaction was performed.
Results: CPAP adherence to CMS criteria for 90 and 365 days was 45.6 % and 44.7 %, respectively, whereas adherence to research criteria was 57.0 % and 54.1 %, respectively. Middle age, high age, and high apnea ratio independently increased CPAP adherence. Conversely, a high rapid eye movement apnea-hypopnea index ratio decreased CPAP adherence. Although high body mass index (BMI) had no independent effect on adherence, its interaction with high 3 % oxygen desaturation index increased 90-day CPAP adherence. However, high BMI decreased 90-day CPAP adherence in males. The interaction between middle age and high BMI was associated with decreased CPAP adherence over 365 days.
Conclusions: Adherence to CPAP in real-world settings is modest. Various factors influence CPAP adherence. BMI may exert varied effects on CPAP adherence depending on the accompanying factors.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.rmed.2024.107815 | DOI Listing |
Sleep Breath
September 2025
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, 1873 Rama IV Road, Pathum Wan, Bangkok, 10330, Thailand.
Purpose: Armodafinil has been approved for treating excessive daytime sleepiness (EDS) in OSA patients who still experience EDS after adequately treated with CPAP. However, the effectiveness of armodafinil administration in OSA patients with suboptimal CPAP usage and persistent EDS remains unexplored.
Method: A 12-week prospective cohort study enrolled 33 moderate to severe OSA patients with suboptimal CPAP usage (2- < 4 h/night) who experienced EDS and were naïve to armodafinil.
Behav Sleep Med
September 2025
School of Nursing, University of Pittsburgh, Pittsburgh, PA, USA.
Introduction: Women are less adherent to continuous positive airway pressure (CPAP) treatment than men, but the reasons remain unclear. This study explored women's unique challenges, experiences, and support needs during CPAP initiation and adherence.
Methods: Semi-structured interviews were conducted with 27 women who initiated CPAP for obstructive sleep apnea (OSA).
J Clin Med
August 2025
Department of Cardiology, Marmara University, 34899 Istanbul, Turkey.
Cardiac Syndrome X (CSX) is associated with significant physical and psychiatric morbidity despite no obvious effect on long-term mortality. Obstructive sleep apnea (OSA) is a prevalent condition in close association with numerous cardiovascular diseases. The precise relation between CSX and OSA remains unclear.
View Article and Find Full Text PDFJ Clin Med
August 2025
Cleveland Clinic Florida, Weston, FL 33331, USA.
: Obstructive sleep apnea (OSA) is a prevalent disorder characterized by airway collapse during sleep. Continuous positive airway pressure (CPAP) is first-line treatment but adherence can decay over time due to intolerance. Hypoglossal nerve stimulation (HNS) has emerged as an alternative, especially for CPAP-intolerant patients.
View Article and Find Full Text PDFLife (Basel)
July 2025
IRCCS Fondazione Don Carlo Gnocchi, 20148 Milan, Italy.
Obstructive sleep apnea (OSA) is a prevalent and heterogeneous sleep disorder associated with significant health and societal burdens. While continuous positive airway pressure (CPAP) remains the gold standard treatment, its limitations in adherence and patient tolerance have highlighted the need for alternative therapies. Positional therapy (PT), which targets apneas that occur predominantly in the supine position, has emerged as a promising option for individuals with positional OSA (POSA).
View Article and Find Full Text PDF